Libo Yang

1.3k total citations
65 papers, 906 citations indexed

About

Libo Yang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Libo Yang has authored 65 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Libo Yang's work include Breast Cancer Treatment Studies (10 papers), HER2/EGFR in Cancer Research (10 papers) and Metal-Organic Frameworks: Synthesis and Applications (8 papers). Libo Yang is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), HER2/EGFR in Cancer Research (10 papers) and Metal-Organic Frameworks: Synthesis and Applications (8 papers). Libo Yang collaborates with scholars based in China, United States and Taiwan. Libo Yang's co-authors include Hong Bu, Yan Qiu, Ai‐Xin Zhu, Bin Zhao, Quan‐Qing Xu, Yong Yang, Guoying Zhang, Shaobin Jia, Zhang Zhang and Ruiqian Li and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Current Biology.

In The Last Decade

Libo Yang

60 papers receiving 894 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Libo Yang China 22 383 299 243 119 109 65 906
Wen Gu China 21 368 1.0× 148 0.5× 269 1.1× 197 1.7× 92 0.8× 74 1.1k
Ruifeng Li China 20 792 2.1× 224 0.7× 212 0.9× 119 1.0× 23 0.2× 61 1.3k
Hongxu Liu China 15 471 1.2× 225 0.8× 175 0.7× 262 2.2× 21 0.2× 38 1.0k
Hanako Kobayashi United States 19 519 1.4× 326 1.1× 218 0.9× 94 0.8× 21 0.2× 32 1.2k
Irina Alho Portugal 18 362 0.9× 99 0.3× 411 1.7× 72 0.6× 78 0.7× 41 852
Pradeep K. Singh United States 16 666 1.7× 182 0.6× 146 0.6× 41 0.3× 112 1.0× 30 1.3k
Yuting Chen China 22 497 1.3× 191 0.6× 220 0.9× 129 1.1× 20 0.2× 68 1.1k
Derek J. Erstad United States 19 287 0.7× 270 0.9× 347 1.4× 196 1.6× 24 0.2× 50 1.2k
Arkadiusz Bonna Poland 19 403 1.1× 68 0.2× 220 0.9× 97 0.8× 38 0.3× 47 1.1k
Jon Rosen United States 18 460 1.2× 140 0.5× 462 1.9× 118 1.0× 37 0.3× 24 1.6k

Countries citing papers authored by Libo Yang

Since Specialization
Citations

This map shows the geographic impact of Libo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Yang more than expected).

Fields of papers citing papers by Libo Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Yang. The network helps show where Libo Yang may publish in the future.

Co-authorship network of co-authors of Libo Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Libo Yang. A scholar is included among the top collaborators of Libo Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libo Yang. Libo Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hua, Ji, Sicheng Liu, Libo Yang, et al.. (2025). miR-28–3p suppresses gastric cancer growth and EMT-driven metastasis by targeting the ARF6/Hedgehog axis. Molecular and Cellular Probes. 79. 102010–102010.
2.
Jiang, Wei, et al.. (2025). A copper-catalyzed enantioselective cycloaddition/amination cascade of azomethine imines, alkynes and O-benzoylhydroxylamines. Organic Chemistry Frontiers. 12(10). 3184–3190. 1 indexed citations
4.
Wang, Lu, Maozhang Tian, Wenfeng Song, et al.. (2024). Directional oil extraction: A new application of MXene as an oil development agent in petroleum exploration and production. Applied Surface Science. 686. 162119–162119.
5.
Yang, Libo, Ruochen Zhang, Jingang Su, et al.. (2024). Preparation and properties of thermal yellowing resistant polyvinylidene chloride resin. Advanced Composites and Hybrid Materials. 8(1). 3 indexed citations
6.
Chen, Limin, et al.. (2024). FA2H controls cool temperature sensing through modifying membrane sphingolipids in Drosophila. Current Biology. 34(5). 997–1009.e6. 2 indexed citations
7.
Liu, Yajuan, Ru Yan, Libo Yang, et al.. (2023). Aspirin ameliorates atherosclerotic immuno-inflammation through regulating the Treg/Th17 axis and CD39-CD73 adenosine signaling via remodeling the gut microbiota in ApoE-/- mice. International Immunopharmacology. 120. 110296–110296. 24 indexed citations
8.
Xie, Yuxin, Libo Yang, Yanqi Wu, Hong Zheng, & Qiheng Gou. (2022). Adjuvant endocrine therapy in patients with estrogen receptor-low positive breast cancer: A prospective cohort study. The Breast. 66. 89–96. 8 indexed citations
9.
Qiu, Yan, Libo Yang, Honghong Liu, & Xiaobo Luo. (2021). Cancer Stem Cell-Targeted Therapeutic Approaches for Overcoming Trastuzumab Resistance in HER2-Positive Breast Cancer. Stem Cells. 39(9). 1125–1136. 27 indexed citations
10.
Yang, Libo, Chunyan Li, Guoying Zhang, et al.. (2021). A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer. Frontiers in Oncology. 11. 686044–686044. 32 indexed citations
12.
Yang, Libo, Bo Fu, Yan Li, et al.. (2020). Prediction model of the response to neoadjuvant chemotherapy in breast cancers by a Naive Bayes algorithm. Computer Methods and Programs in Biomedicine. 192. 105458–105458. 18 indexed citations
13.
Deng, Yang, Libo Yang, Zhang Zhang, et al.. (2020). Automated quantitative analysis of Ki-67 staining and HE images recognition and registration based on whole tissue sections in breast carcinoma. Diagnostic Pathology. 15(1). 65–65. 32 indexed citations
14.
Yang, Libo, Ting Lei, Li Li, et al.. (2019). BRCA1/2 mutation spectrum in Chinese early-onset breast cancer. Translational Cancer Research. 8(2). 483–490. 1 indexed citations
15.
Zhu, Lili, Na Zhang, Ru Yan, et al.. (2019). Hyperhomocysteinemia induces vascular calcification by activating the transcription factor RUNX2 via Krüppel-like factor 4 up-regulation in mice. Journal of Biological Chemistry. 294(51). 19465–19474. 25 indexed citations
17.
Wei, Xiaoxia, et al.. (2017). [Ki-67 expression and its effect on response to neo-adjuvant chemotherapy in invasive breast cancer].. PubMed. 46(12). 817–821. 3 indexed citations
18.
Yao, Shutong, Hua Tian, Li Zhao, et al.. (2016). Oxidized high density lipoprotein induces macrophage apoptosis via toll-like receptor 4-dependent CHOP pathway. Journal of Lipid Research. 58(1). 164–177. 27 indexed citations
19.
Pu, Tianjie, Peng Guo, Yan Qiu, et al.. (2015). Quantitative real-time polymerase chain reaction is an alternative method for the detection of HER-2 amplification in formalin-fixed paraffin-embedded breast cancer samples.. PubMed. 8(9). 10565–74. 8 indexed citations
20.
Wang, Lu, et al.. (2010). NtGNL1 Plays an Essential Role in Pollen Tube Tip Growth and Orientation Likely via Regulation of Post-Golgi Trafficking. PLoS ONE. 5(10). e13401–e13401. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026